- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03924622
Pressure Injury Prevention in AE and PFC
March 1, 2022 updated by: Elizabeth Bridges, University of Washington
Prevention of Pressure Injuries During Aeromedical Evacuation or Prolonged Field Care
This study evaluates the effect of a multilayer skin dressing (Mepilex) placed on the sacrum or a fluid filled pad (LiquiCell) on risk factors for pressure injuries under conditions consistent with military long-distance transport or prolonged field care.
Participants will be assigned to one of six groups - air transport, air transport on a spinal immobilization surface with or without Mepilex or on a field stretcher with or without LiquiCell.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Combat casualties undergoing long distance aeromedical evacuation (AE), particularly casualties who are immobilized because of possible spine injuries, and casualties who required prolonged field care are at increased risk for pressure injuries.
The risk factors pressure and shear are potentially modifiable via solutions appropriate for these austere conditions.
Two interventions (Mepilex and LiquiCell) will be evaluated under conditions simulating military medical transport on a standard stretcher or with spinal immobilization in a vacuum spine board (VSB) or on a military stretcher used under field conditions.
Mepilex is a multi-layer dressing that can be placed on the skin (sacrum/buttocks) and LiquiCell is a pad filled with pockets of fluid that is placed under the back and buttocks.
The effect of these interventions compared to not using them will be studied under the three conditions with or without the intervention (Mepilex or LiquiCell) using measures obtained on the lower back/sacrum including skin interface pressure, oxygen, moisture, and temperature and a cytokine indicating possible tissue damage.
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women
- Age 18 to 55
- Meet the physical standards for military personnel
- Weigh less than 250 pounds
- Be able to remain in the study position for the duration of the study.
Exclusion Criteria
- Previous injuries to sacrum/buttocks with scarring
- History of pressure injuries
- Cardiovascular disease
- Neurological disease that would affect vascular response
- Diabetes
- History of malignancy
- Current skin condition (e.g., eczema or psoriasis)
- Current neck/back pain or history of chronic neck/back pain
- Known vertebral/spinal cord disease/injury (scoliosis, kyphosis, or lordosis)
- Self-reported pregnancy
- Concern about ability to remain in the vacuum spine board for 120 minutes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: Mepilex on Litter + AE Mattress + 30 degree backrest
Intervention: Mepilex
|
Mepilex Border Sacrum dressing is a multi-layered soft silicone dressing that is a recommended strategy to augment standard nursing interventions (i.e., repositioning, offloading) to prevent pressure injuries.
The dressing will be placed on the sacrum.
|
|
No Intervention: Group 2: Without Mepilex on Litter + AE mattress + backrest
Intervention: Control (no Mepilex)
|
|
|
Experimental: Group 3: Mepilex on VSB on AE mattress
Intervention: Mepilex
|
Mepilex Border Sacrum dressing is a multi-layered soft silicone dressing that is a recommended strategy to augment standard nursing interventions (i.e., repositioning, offloading) to prevent pressure injuries.
The dressing will be placed on the sacrum.
|
|
No Intervention: Group 4: Without Mepilex on VSB on AE mattress
Intervention: Control (no Mepilex)
|
|
|
Experimental: Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon litter
Intervention: LiquiCell mat
|
LiquiCell is a thin layer of low-viscosity fluid contained in a series of bursa-like pouches.
Baffles within each pouch channel the liquid to disperse pressure and the volume of liquid in the pouch is so small that there is no pressure-build up.
LiquiCell is available commercially as a 36 X 18-inch mattress overlay (LiquiCell Shear Reducing Mattress Overlay) with a soft pliable top and a non-slip bottom.
The overlay is positioned from the shoulders to below the hips to minimize shear.
|
|
No Intervention: Group 6: PFC Without LiquiCell on Talon Litter
Intervention: Control (no LiquiCell)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Interleukin-1/Total Protein (Skin)
Time Frame: Baseline through study completion - approximately 120 minutes
|
Skin cytokine (IL-1) and total protein will be obtained using a small strip of specialized tape placed on the sacrum/buttocks.
After 1-minute application the tape is removed and analyzed for quantity of interleukin-1 (indicator of skin irritation)
|
Baseline through study completion - approximately 120 minutes
|
|
Change in Transcutaneous Tissue Oxygen (TcPO2)
Time Frame: Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
|
Tissue oxygen is measured continuously on the sacrum using a noninvasive sensor and on the midsternum (midchest) as a control
|
Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
|
|
Change in Skin Moisture (Epidermal and Subepidermal)
Time Frame: Baseline (before lying down) and after 120 minutes supine
|
Two components of skin moisture will be measured on the sacrum using the Delfin MoistureMeter.
The epidermal moisture, which reflects perspiration and subepidermal moisture , which reflects water content of the tissues.
The values range from 1-80, with higher numbers reflecting increased moisture.
|
Baseline (before lying down) and after 120 minutes supine
|
|
Change in Skin Temperature
Time Frame: Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
|
Skin temperature will be measured continuously on the sacrum using a laser doppler probe.
|
Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
|
|
Change in Skin Interface Pressure
Time Frame: Continuously during the supine phase of the study (120 minutes)
|
The pressure between the support surface and the skin will be measured continuously during the supine position using the X Sensor system.
This system measures force/unit area (e.g., pressure).
The peak and average pressure on the sacrum/buttocks will be measured.
|
Continuously during the supine phase of the study (120 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pressure-Discomfort (Category Partitioning Scale-50)
Time Frame: The score will be obtained at baseline and every 30 minutes in the supine position (total 5 measurements).
|
This scale asks the participant to describe in verbal terms the pressure intensity or discomfort associated with the stimulus (i.e., sacral/buttocks pressure or discomfort).
The participant can then fine tune their assessment using a numeric score.
The final score is an analog.
The score ranges from 0-52, with higher scores indicating higher pressure or more severe discomfort.
The investigator will ask the participant to limit their evaluation to the pressure/discomfort sensed on the sacrum/buttocks, but the investigator will also ask the participants to identify on their body where they are experiencing the most pressure/discomfort.
|
The score will be obtained at baseline and every 30 minutes in the supine position (total 5 measurements).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elizabeth Bridges, PhD, RN, University of Washington
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2019
Primary Completion (Actual)
September 23, 2020
Study Completion (Actual)
September 23, 2020
Study Registration Dates
First Submitted
April 10, 2019
First Submitted That Met QC Criteria
April 19, 2019
First Posted (Actual)
April 23, 2019
Study Record Updates
Last Update Posted (Actual)
May 16, 2022
Last Update Submitted That Met QC Criteria
March 1, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00006022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Injury
-
Coloplast A/SCompletedPressure Injury PreventionDenmark
-
Second Affiliated Hospital, School of Medicine,...RecruitingOral Mucosal Pressure InjuryChina
-
King Abdullah Medical CityRecruitingPressure Injury | Pressure Ulcer, Buttock | Pressure Injury Stage 2 | Pressure Ulcers Stage II | BedsoreSaudi Arabia
-
University of GaziantepCompletedNursing Education | Pressure Injury | Medical Device-Related Pressure InjuryTurkey (Türkiye)
-
Saglik Bilimleri UniversitesiEnrolling by invitationPressure Injury | Risk Assessment | Nursing Care | Pressure Injury PreventionTurkey (Türkiye)
-
National Taiwan University HospitalCompletedPressure Injury | Implementation | Alternating Pressure Air MattressTaiwan
-
Ankara Yildirim Beyazıt UniversityAnkara City Hospital BilkentCompletedPressure Injury PreventionTurkey
-
Taipei Medical University WanFang HospitalKaohsiung Medical University Chung-Ho Memorial Hospital; Oneness Biotech Co...Terminated
-
Istanbul Medipol University HospitalMedipol University; Kartal Dr. Lütfi Kirdar City HospitalRecruitingPressure Injury | Skin Lesions | Skin InjuryTurkey (Türkiye)
-
Mehmet Akif Ersoy UniversityMassachusetts College of Pharmacy and Health Science; University of Massachusetts...Not yet recruitingPressure Ulcer Prevention | Pressure InjuriesUnited States
Clinical Trials on Mepilex
-
Melbourne HealthCompleted
-
Molnlycke Health Care ABCompletedVenous Leg Ulcers | Mixed Leg UlcersFrance, Germany, Netherlands, Czech Republic
-
Molnlycke Health Care ABCompleted
-
PD Dr. Jan KottnerCompletedPressure UlcerGermany
-
Molnlycke Health Care ABCompletedPressure Incidence PreventionUnited States
-
The University of Texas Medical Branch, GalvestonShriners Hospitals for Children; Keraplast Technologies, LLCWithdrawnSkin Burn Degree SecondUnited States
-
Molnlycke Health Care ABRecruitingDiabetic Foot Ulcer | Wound; Foot | Venous Leg Ulcer | Wounds | Wound of Skin | Wound LegUnited States
-
Calvary Hospital, Bronx, NYIntegra LifeSciences CorporationCompletedNeuropathic Diabetic Foot UlcerUnited States
-
Molnlycke Health Care ABRecruiting
-
The University of Texas Medical Branch, GalvestonWithdrawnPartial-thickness BurnUnited States